Bottom line
OAYEX vs FSPSX: the short answer
OAYEX (Oakmark International Small Cap Fund) and FSPSX (Fidelity International Index Fund) are both mutual funds.
But FSPSX is far broader, holding 705 positions to 65 for OAYEX, so beyond the top names it adds exposure OAYEX doesn't have.
FSPSX is cheaper at 0.035% vs 1.17% — a difference of $114 a year per $10,000 invested.
Over five years, FSPSX returned +9.1% a year vs +9.0% for OAYEX (reporting dates differ).
Updated Nov 19, 2026
OAYEX vs FSPSX side by side
| OAYEX | FSPSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Oakmark (Harris) | Fidelity |
| Category | International Stock | International Stock |
| Expense ratio | 1.17% | 0.035% |
| Annual cost per $10k | $117 | $3.5 |
| 10-yr cost on $10k (prospectus) | $1,420 | $45 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +29.7% | +32.0% |
| 5-yr return (annualized) | +9.0% | +9.1% |
| 10-yr return (annualized) | +8.2% | +8.4% |
| Best quarter | +27.8% | +18.3% |
| Worst quarter | −38.3% | −23.0% |
| Net assets (fund) | $1.2B | $83.7B |
| Number of holdings | 65 | 705 |
| Portfolio turnover | 37% | 4% |
| Returns as of | Dec 31, 2025 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
OAYEX and FSPSX share none of their top holdings.
OAYEX top 10
- Atea ASA — 3.28%
- Julius Baer Group Ltd — 3.12%
- Convatec Group PLC — 2.69%
- Fielmann Group AG — 2.62%
- Fixed Income Clearing Corp. — 2.55%
- Azelis Group NV — 2.52%
- Davide Campari-Milano NV — 2.50%
- Amplifon SpA — 2.49%
- Kimberly-Clark de Mexico SAB de CV — 2.45%
- Azimut Holding SpA — 2.43%
FSPSX top 10
- Asml Holding Nv — 2.82%
- Hsbc Holdings Plc — 1.45%
- Roche Holding Ag — 1.33%
- Astrazeneca Plc — 1.30%
- Novartis Ag — 1.29%
- Nestle Sa — 1.18%
- Shell Plc — 1.08%
- Siemens Ag — 1.07%
- Bhp Group Ltd — 1.02%
- Mitsubishi Ufj Financial Group Inc — 0.95%
FAQ
What is the difference between OAYEX and FSPSX?
Which is cheaper, OAYEX or FSPSX?
Should I own both OAYEX and FSPSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.